Inquiries · Recommendations
Public Inquiry Recommendations
1,814 tracked recommendations
35 inquiries
687 match current filters
Page 7 of 14
Recommendations issued by UK statutory and non-statutory inquiries, with their tracked government response and supporting evidence.
Browse by inquiry
| Inquiry | Recs | Accepted |
|---|---|---|
| Mid Staffs Inquiry | 290 | 281 |
| Manchester Arena Inquiry | 169 | 169 |
| IICSA | 107 | 96 |
| Muckamore Abbey Inquiry | 106 | — |
| Grenfell Tower Inquiry | 104 | 104 |
| Infected Blood Inquiry | 103 | 102 |
| Hyponatraemia Inquiry | 96 | 96 |
| Fuller Inquiry | 92 | 71 |
| Leveson Inquiry | 92 | 77 |
| Vale of Leven Inquiry | 75 | 75 |
| Baha Mousa Inquiry | 73 | 72 |
| Southport Inquiry | 67 | — |
| RHI Inquiry | 45 | 44 |
| COVID-19 Inquiry | 44 | 24 |
| Morecambe Bay Investigation | 44 | 44 |
| Brook House Inquiry | 33 | 28 |
| Bichard Inquiry | 31 | 31 |
| Angiolini Inquiry | 30 | 29 |
| Post Office Horizon Inquiry | 27 | 25 |
| Jermaine Baker Inquiry | 26 | 22 |
| Edinburgh Tram Inquiry | 24 | 21 |
| Daniel Morgan Panel | 23 | 21 |
| Cranston Inquiry | 18 | — |
| Paterson Inquiry | 17 | 15 |
| HIA Inquiry | 12 | 12 |
| Scottish Hospitals Inquiry | 11 | 11 |
| Anthony Grainger Inquiry | 9 | 9 |
| Al-Sweady Inquiry | 9 | 9 |
| Hillsborough Panel | 9 | 5 |
| Fingerprint Inquiry | 9 | 9 |
| ICL Inquiry | 7 | 6 |
| Litvinenko Inquiry | 5 | 5 |
| Azelle Rodney Inquiry | 3 | 3 |
| Billy Wright Inquiry | 3 | 3 |
| Penrose Inquiry | 1 | 1 |
Recommendations
| Code | Recommendation | Inquiry | Response |
|---|---|---|---|
| IBI-7a(i) |
Transfusion Committees and Tranexamic Acid - England
In England, Hospital Transfusion Committees and transfusion practitioners take steps to ensure that consideration of tranexamic acid be on every hospital surgical …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-7a(ii) |
Tranexamic Acid - Scotland, Wales and NI
In Scotland, Wales and Northern Ireland offering the use of tranexamic acid should be considered a treatment of preference in respect of …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7a(iii) |
Transfusion Performance Benchmarking
Consideration be given to standardising and benchmarking transfusion performance between hospitals in order to deliver better patient blood management
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7b |
Transfusion 2024 Review Progress
Review of progress towards the Transfusion 2024 recommendations: Progress in implementation of the Transfusion 2024 recommendations be reviewed, and next steps be …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7c |
Transfusion Laboratory Staffing
Transfusion laboratories: Transfusion laboratories should be staffed (and resourced) adequately to meet the requirements of their functions.
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-7d |
Training in Transfusion Medicine
Training in Transfusion Medicine: That those bodies concerned with undergraduate and postgraduate training across the UK of those people who are, or …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-7e |
Implementing SHOT Reports
Implementing SHOT reports: That all NHS organisations across the UK have a mechanism in place for implementing recommendations of Serious Hazard of …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-7f(i) |
Transfusion Outcome Framework
Establishing the outcome of every transfusion: That a framework be established for recording outcomes for recipients of blood components. That those records …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7f(ii) |
NHSBT Transfusion Outcome Funding
Establishing the outcome of every transfusion: To the extent that the funding for digital transformation does not already cover the setting up …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-7f(iii) |
Blood Tracking Systems Funding
Establishing the outcome of every transfusion: That funding for the provision of enhanced electronic clinical systems in relation to blood transfusion be …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-8a |
Pre-1996 Transfusion Testing
When doctors become aware that a patient has had a blood transfusion prior to 1996, that patient should be offered a blood …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-8b |
New Patient Registration Screening
As a matter of routine, new patients registering at a practice should be asked if they have had such a transfusion.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9a |
Haemophilia Peer Review
That peer review of haemophilia care should continue to occur as presently practised, with any necessary support being provided by NHS Trusts …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9b |
Trust/Board Action on Peer Reviews
That NHS Trusts and Health Boards should be required to deliberate on peer review findings and give favourable consideration to implementing the …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9c |
Five-Year Peer Review Cycle
A peer review of each centre should take place not less than once every five years.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9d |
Haemophilia Centre Resources
The necessary administrative and clinical resources should be provided by hospital trusts and boards, integrated care boards, and service commissioners to facilitate …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9e |
Recombinant Products Over Plasma-Derived
Recombinant coagulation factor products should be offered in place of plasma-derived ones where clinically appropriate. Service commissioners should ensure that such treatment …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-9f |
National Haemophilia Database Support
That the National Haemophilia Database, run by the UKHCDO, merits the support of additional central funding.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-10a(i) |
Patient Satisfaction in Clinical Audits
A clinical audit should as a matter of routine include measures of patient satisfaction or concern, and these should be reported to …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-10a(ii) |
Charity Funding for Patient Advocacy
That the following charities receive funding specifically for patient advocacy: the UK Haemophilia Society; the Hepatitis C Trust; Haemophilia Scotland; the Scottish …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-10a(iii) |
Additional Charity Support
That favourable consideration be given to other charities and organisations supporting people infected and affected that were granted core participant status (as …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-10a(iv) |
Thalassaemia Society Support
Particular consideration be given, together with the UK Thalassaemia Society and the Sickle Cell Society, to how the needs of patients with …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-10a(v) |
Yellow Card System Prominence
Steps be taken to give greater prominence to the online Yellow Card system to those receiving drugs or biological products, or who …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-11a |
Ministerial Power to Call Inquiries
That a minister should retain the power to call an inquiry as the minister sees fit, in accordance with the Inquiries Act …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-11b |
Parliamentary Referral to PACAC
If there is sufficient support from within Parliament for there to be an inquiry, the question whether there should be one should …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-11c |
PACAC Recommendation Power
If it appears to PACAC that there is sufficient concern to justify a public inquiry, either because what happened and why has …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-11d |
Ministerial Reasons for Disagreement
If the minister disagrees with the recommendation, they must set out in detail and publish reasons for this disagreement which are sufficient …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-12a |
Implementation Commitment Within 12 Months
Within the next 12 months, the Government should consider and either commit to implementing the recommendations which I make, or give sufficient …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-12b |
Parliamentary Progress Report
During that period, and before the end of this year – the Government should report back to Parliament as to the progress …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-12c |
No Delay to Second Interim Response
This timetable should not interfere with earlier consideration and response to the Recommendations of the Second Interim Report of the Inquiry.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-12d |
PACAC Oversight of Implementation
The Public Administration and Constitutional Affairs Committee (“PACAC”) should review both the progress towards responding to the Inquiry’s recommendations and, to the …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-12e |
PACAC Role for Future Inquiries
PACAC should accept the role in respect of any future statutory inquiry of reviewing the government’s timetable for consideration of recommendations, and …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IR1-1 |
Interim Compensation Payments
An interim payment, of no less than £100,000, should be paid to all those infected and all bereaved partners currently registered with …
|
Infected Blood Inquiry (2022) | Accepted |
| IR2-1 |
Scheme Eligibility - Infected and Affected Persons
I recommend that the scheme should offer redress to those infected with HCV and/or HIV, and/or HBV (limited to chronic HBV unless …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-2 |
Eligibility Conditions for Infected Persons
I recommend that the conditions of eligibility for admission of relevant infected persons to the scheme should be that: a) they have …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-3 |
Standard of Proof and Automatic Eligibility
As above, save that (a) the last bullet point should read: "eligibility is accepted if the information available points towards eligibility and …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-4 |
Affected Persons Categories
I recommend that the following relevant affected persons should be admitted to the scheme: a) spouses, civil partners and long term cohabitees …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-5 |
Classification of Infections and Severity
I recommend that infections eligible for compensation should be classified in the following manner: a) there should be defined categories for each …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-6 |
Categories of Loss and Award Heads
I recommend that the appropriate award in any case should be composed under the following categories of loss, applicable to both eligible …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-7 |
No Exemplary Damages but Court Access Preserved
I recommend that there should be no award for exemplary damages, though it should remain open to a claimant to pursue such …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-8 |
Tariff-Based Compensation Framework
I recommend that the Government should approve a scheme setting out a framework of tariff based compensation for eligible infected and affected …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-9 |
Status of Awards and Legal Rights
I recommend that, with reference to the status of awards: a) eligible infected and affected persons should not be required to accept …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-10 |
Form of Awards - Lump Sum and Periodical Payments
I recommend that: a) awards should be made in a lump sum in respect of an Injury Impact Award, Social Impact Award, …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-11 |
Interest on Past Losses
I recommend that interest be payable on awards for past financial losses and past provision of care, from the date of infection …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-12 |
Interim Payments for Bereaved Families
I recommend that an interim payment of £100,000 should be paid to recognise the deaths of people to date unrecognised and alleviate …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-13 |
Relationship with Support Schemes and Benefits
I recommend that, with regard to the relationship between compensation, support payments and benefits: a) in assessing compensation under the scheme, no …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-14 |
Arms Length Body Administration
I recommend that an Arms Length Body (ALB) should be set up to administer the compensation scheme, with guaranteed independence of judgement, …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-15 |
Support Services for Applicants
I recommend that the scheme should include provision of the following support services to be provided without charge to the applicant: a) …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-16 |
Central Delivery with Devolved Support
I recommend that the compensation scheme should be delivered by one central body, appropriately resourced and staffed. Current support schemes should however …
|
Infected Blood Inquiry (2023) | Accepted |
| IR2-17 |
Bespoke Psychological Service
I recommend that without delay steps be taken to provide a bespoke psychological service in England.
|
Infected Blood Inquiry (2023) | Accepted |